Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis

• Egile Nagusiak: Bita Shahrami (Egilea), Farhad Najmeddin (Egilea), Mohammad Reza Rouini (Egilea), Atabak Najafi (Egilea), Kourosh Sadeghi (Egilea), Shahideh Amini (Egilea), Seyedeh Sana Khezrnia (Egilea), Hamid Reza Sharifnia (Egilea), Mojtaba Mojtahedzadeh (Egilea)
• Formatua: Liburua
• Argitaratua: Tabriz University of Medical Sciences, 2020-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Purpose: Although the current widespread use of amikacin is in intra-abdominal sepsis treatment, its pharmacokinetic changes in the present setting are not yet well known. This study was aimed to evaluate the amikacin pharmacokinetic profile in critically ill patients with intraabdominal sepsis comp...